Mental health screening measures like the DASS-21 can be useful in determining which clients might need to be referred for ...

Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese Adults with Generalized Anxiety ...

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that it presented data showing the effectiveness of ...

Psychedelics Excite Cells in Hippocampus to Reduce Anxiety Sep. 24, 2024 — A classic psychedelic, similar to LSD, psilocybin and mescalin, was found to activate a cell type in the brain that ...

For many, anxiety can get worse at night when there are fewer distractions, and your mind begins to wander. Here’s what helped Leah in managing her nighttime anxiety. Share on Pinterest It ...

Understanding the top five stressors faced by retirees and addressing them through effective financial planning is crucial.

"This effort highlights the power of large-scale genetic studies to dissect the complex pathogenesis of anxiety demonstrating how multiple genes acting on different brain functions contribute to ...

12-month efficacy data from Phase 2 study of CYB003 in MDD expected in early Q4 2024 - - Phase 2 topline efficacy and safety results for CYB004 in Generalized Anxiety Disorder (“GAD”) expected ...

Concerns about our future are valid — but they aren't always shared by those who are fighting to survive in the present.

However, research on chakras and their role in the development or management of anxiety is limited. Feeling anxious every now and then is a natural response to stressors. But if you experience ...

BYD's ability to scale production, reduce ASPs, and expand profit margins support its long-term investment thesis. Read why I ...

our proprietary deuterated dimethyltryptamine program for the treatment of Generalized Anxiety Disorder. We have made significant progress in preparing for our upcoming Phase 3 programs and have ...